₹ 520.85
7.15 (1.39%)
L
Lincoln Pharmaceuticals
₹ 520.85
Lincoln Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of Lincoln Pharmaceuticals as of Q2 Sep 2026 stands at ₹10.20. This is a 43.62% fall quarter on quarter and 2.20% growth same quarter last year. For the FY2026 the EPS of Lincoln Pharmaceuticals stands at ₹43.88. This is a 6.74% growth compared with FY2025.
Lincoln Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

